These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30517995)

  • 41. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update Summary.
    Taplitz RA; Kennedy EB; Flowers CR
    J Oncol Pract; 2018 Apr; 14(4):250-255. PubMed ID: 29517953
    [No Abstract]   [Full Text] [Related]  

  • 43. Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.
    Lynn JJ; Chen KF; Weng YM; Chiu TF
    Hematol Oncol; 2013 Dec; 31(4):189-96. PubMed ID: 23303687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever.
    McMeekin DS; Gazzaniga C; Berman M; DiSaia P; Manetta A
    Gynecol Oncol; 1996 Aug; 62(2):247-53. PubMed ID: 8751557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
    Aquino VM; Herrera L; Sandler ES; Buchanan GR
    Cancer; 2000 Apr; 88(7):1710-4. PubMed ID: 10738231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
    Chamilos G; Bamias A; Efstathiou E; Zorzou PM; Kastritis E; Kostis E; Papadimitriou C; Dimopoulos MA
    Cancer; 2005 Jun; 103(12):2629-35. PubMed ID: 15856427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Febrile neutropenia: median door-to-needle time - results of an initial audit.
    Ali N; Baqir M; Hamid A; Khurshid M
    Hematology; 2015 Jan; 20(1):26-30. PubMed ID: 24724830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
    Vidal L; Paul M; Ben dor I; Soares-Weiser K; Leibovici L
    J Antimicrob Chemother; 2004 Jul; 54(1):29-37. PubMed ID: 15201227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A simple intervention to improve antibiotic treatment times for neutropenic sepsis.
    Botten J; Beard J; Zorzi A; Thompson A
    Acute Med; 2016; 15(1):3-6. PubMed ID: 27116580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of fever and neutropenia in paediatric cancer patients: room for improvement?
    Haeusler GM; Sung L; Ammann RA; Phillips B
    Curr Opin Infect Dis; 2015 Dec; 28(6):532-8. PubMed ID: 26381997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of fever and neutropenia in children with cancer.
    Vedi A; Pennington V; O'Meara M; Stark K; Senner A; Hunstead P; Adnum K; Londall W; Maurice L; Wakefield C; Cohn RJ
    Support Care Cancer; 2015 Jul; 23(7):2079-87. PubMed ID: 25533581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia.
    Vedi A; Cohn R
    J Paediatr Child Health; 2013 Mar; 49(3):170-8. PubMed ID: 22136103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ambulatory management of chemotherapy-induced fever and neutropenia in adult cancer patients.
    Davis DD; Raebel MA
    Ann Pharmacother; 1998 Dec; 32(12):1317-23. PubMed ID: 9876814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early discharge and ambulatory care of low-risk patients with neutropenic fever in Australia.
    Hocking C; Taylor A; Hayward A
    Intern Med J; 2013 May; 43(5):591-5. PubMed ID: 23668271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.
    Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Cumsille MA; O'Ryan ML; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    J Clin Oncol; 2004 Sep; 22(18):3784-9. PubMed ID: 15365075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extensive stage small cell lung cancer: determining suitability for outpatient management of febrile neutropenia.
    Rapp JS; Perry MC; Rotche RM
    Semin Oncol; 1996 Apr; 23(2):xv-xxii; discussion xxii. PubMed ID: 8623054
    [No Abstract]   [Full Text] [Related]  

  • 58. An audit of febrile neutropenia cases from a rural cancer center in India.
    Patil VM; Chakarborty S; Kumar MS; Geetha M; Dev S; Samuel S; Ahmed G; Nayanar SK; Vineetha R; Nair CK
    Indian J Cancer; 2014; 51(4):487-90. PubMed ID: 26842173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The outpatient management of febrile neutropenia in cancer patients.
    Freifeld AG; Pizzo PA
    Oncology (Williston Park); 1996 Apr; 10(4):599-606, 611-2; discussion 615-6. PubMed ID: 8723296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia.
    Ko BS; Ahn S; Lee YS; Kim WY; Lim KS; Lee JL
    Support Care Cancer; 2015 Sep; 23(9):2799-804. PubMed ID: 25663578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.